Learn More
Invitrogen™ Human BRCA2 (aa 1255-1385) Control Fragment Recombinant Protein
Description
Highest antigen sequence indentity to the following orthologs: Mouse (50%), Rat (50%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-82936 (PA5-82936. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.

Specifications
Specifications
Accession Number | P51587 |
Concentration | ≥5.0 mg/mL |
For Use With (Application) | Blocking Assay, Control |
Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
Gene ID (Entrez) | 675 |
Name | Human BRCA2 (aa 1255-1385) Control Fragment |
Quantity | 100 μL |
Regulatory Status | RUO |
Gene Alias | brca 2; BRCA1/BRCA2-containing complex, subunit 2; BRCA2; brca-2; BRCA2 DNA repair associated; BRCA2, DNA repair associated; BRCC2; breast and ovarian cancer susceptibility gene, early onset; breast and ovarian cancer susceptibility protein 2; breast cancer 2; breast cancer 2 tumor suppressor; breast cancer 2, early onset; breast cancer 2, mutation 1, University of Wisconsin-Madison; breast cancer susceptibility protein 2; breast cancer type 2 susceptibility protein; Breast cancer type 2 susceptibility protein homolog; BROVCA2; FACD; FAD; FAD1; FANCB; FANCD; FANCD1; Fanconi anemia group D1 protein; Fanconi anemia group D1 protein homolog; GLM3; mutant BRCA2; PNCA2; RAB163; RP11-298P3.4; XRCC11 |
Common Name | BRCA2 |
Show More |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.